The practical and theoretical importance of attempts to isolate and characterize histocompatibility antigens is well recognized. The availability of purified antigenic materials should allow more precise methods for analyzing the mechanisms of such complex phenomena as homograft rejection, acquired immunological tolerance, and immunological enhancement. Furthermore, a knowledge of the tissue distribution and cellular localization of particular antigens may provide an insight into the normal physiological significance of these substances which have been detected primarily because of their untoward influence in the homotransplantation of tissues.
The murine lymphoblast L-5178Y, a cell line that can be grown on a large scale in tissue culture, has been shown to be a convenient starting material for the isolation of mouse histocompatibility antigens. Previous reportsl 2 indicated that a soluble fraction prepared from sonic lysates of L-5178Y could sensitize mice of an homologous strain to show an accelerated rejection of grafts of tumor cells. The soluble material also caused an accelerated rejection of tail skin homografts but did not affect the survival time of orthotopically placed skin homografts. The antigens affecting the latter were found in the particulate fractions of the cells.
This report describes the isolation of an antigenic fraction from homogenates of L-5178Y which will cause an accelerated rejection of skin homografts as well as of tumor grafts, and which will also combine with the hemagglutinating and cytotoxic antibodies of mouse isoimmune sera. The antigenic activities were found to be associated with the high density lipoproteins of the cell. The chromosome complement of the L-5178Y cell line may be characterized as "heteroploid" or as "hyperdiploid." Karyotypic analysis indicated considerable restructuring of chromosomes as evidenced by the presence of [1] [2] [3] [4] [5] "minutes" in almost every one of 50 examined, as well as some abnormally long telocentrics. No metacentrics were noted. The mode was 43 chromosomes with a range from 41 to 45 per cell. Examination of this cell line after parallel in vivo and in vitro passage for one year revealed no essential shift in these karyotypic features.4
Extraction procedure: In a previous report2 it was demonstrated that the microsome fraction prepared from cells homogenized in 0.15 M NaCl was the most active fraction in sensitizing animals to show an accelerated rejection of skin homografts, while the soluble fraction was completely inactive. When the cell homogenate was fractionated in sucrose, however, some activity remained in the soluble fraction. It soon became apparent that the antigenic activity was associated with a low density material that would float in high sucrose concentrations. The method of extraction which we have evolved yields an antigenic fraction from the cell homogenate in two steps, as outlined in Figure 1 Biological tests: All tests of skin homograft rejection were carried out in C57B1/6 mice. The mice were immunized by intraperitoneal injections of the antigenic fractions and grafted with DBA/2 skin 3-4 days later. Homografts of body-skin were placed orthotopically following the methods described by Billingham.6 The bandages were removed on the 6th day after grafting and the grafts visually scored for the percentage of surviving tissue on each following day. The day on which the graft was completely rejected was noted. The median survival times (MST) with 95% confidence limits were calculated by Litchfield's6 nomograph method.
The ability of the antigenic fractions to sensitize a mouse to show an accelerated rejection of a tumor graft was tested in C3H mice. Fractions to be tested were injected intraperitoneally and the animals challenged with 2 X 106 L-5178Y cells injected intraperitoneally 5-6 days later. Six days after the challenge the ascites fluid that formed, if any, was removed and the number of nonviable cells determined by eosin staining. Unimmunized animals yielded 0.3-1.2 ml of ascitic fluid containing 1.5-4.0 X 108 cells per ml of which no more than 10% were nonviable cells. Animals immunized with active preparations yielded either no ascitic fluid at all, or smaller amounts of fluid than controls that contained fewer cells per ml of which more than 10% were nonviable. The fluids obtained from each animal of a control or immunized group were scored separately.
Serological tests: The antigenicity of the various preparations also was shown by the specific absorption of isoimmune sera and by the production of humoral antibodies in homologous strains of mice after immunization with the extracts. Antisera were prepared in C3H and C57B1/6 mice against L-5178Y cells and against normal PROC. N. A. S. DBA/2 tissues following a series of 3-4 injections with cell doses varying from 5 X 106 to 25 X 106 cells per injection. The titers of the particular antisera used in these studies will be denoted in the appropriate tables. Antisera were also prepared in DBA/2 and C57B1/6 mice against normal C3H tissues. All antisera were frozen and stored at -60 to -70'C.
Agglutination tests were performed by diluting the isoimmune sera with 1.5% polyvinylpyrrolidone (PVP) as described by Stimpfling7 and mixing two drops of the serum dilution with one drop of a red blood cell suspension (3% in physiological saline). The mixture was incubated 90 min at 370C. After light centrifugation and the addition of 0.5 ml of saline, the amount of agglutination was determined by gently agitating the cell sediment. Agglutination scores of 0 (no visible clumps) to 4 (one single clump) were used. Tubes containing two drops of 1.5% PVP in place of serum were included as controls. Cells for the agglutination tests were prepared fresh each day.
The cytotoxic test was performed by mixing 0.1 ml of several serum dilutions (mammalian Ringer used as diluent) with 0.1 ml of a washed lymph node cell suspension containing approximately 5 X 106 cells per ml. After 5-min incubation at room temperature, 0.1 ml of an appropriately diluted (usually 3: 1 with saline) fresh-frozen guinea pig serum was added as a source of complement. The test mixture was incubated for 45 min at 370C, by which time the cells had settled sufficiently so that most of the supernatant solution could be removed. A solution of trypan blue (1/2,000 dilution in mammalian Ringer) was added, and the proportion of stained cells was rapidly determined microscopically (350 X magnification). Control tubes of normal serum and guinea pig serum were included with each series of tests, and, as a check on the conditions of the test, the control tubes were evaluated after those containing antiserum.
The procedure for the absorptions of the immune sera was as follows: 0.4 ml of several serum dilutions were mixed with the appropriate amount of antigen and the mixture incubated for 30 min at room temperature and 30 min in the refrigerator. The tubes were then centrifuged for 45 min at 25,000 X q, and the supernatant fluid titrated for hemagglutinins or cytotoxins.
Inhibition of agglutination with extracts was obtained by adding one drop of diluted extract suspension to each tube of the serially diluted antiserum (doubling dilutions). The serum-extract mixture was allowed to incubate for 30 min at room temperature before a saline suspension of red blood cells was added. After 90 min further incubation, the degree of agglutination in the control tubes (saline added in place of extract) and those treated with varying dilutions of extract was evaluated.
Mice were immunized with varying amounts of P2, measured as protein, and injected intraperitoneally. Pre-immunization sera were obtained and frozen to be used as controls of the agglutination test. Five animals were included in each group and the sera of each collected and pooled at various times following hyperimmunization.
Results.-Homograft rejection: The effects upon the MST of DBA/2 skin homografts on mice which had received prior injections of the fractions obtained during the extraction procedure are shown in Table 1 . The sedimentation of antigenically active material in 0.25 M sucrose during ultracentrifugation was indicated because the residue, R1, caused an accelerated rejection, whereas the supernatant, S,, was inactive. When the R1 fraction was extracted with the 1.5 M sucrose, the antigenically active material floated and finally appeared in the pellicle that formed after prolonged centrifugation, P1. The failure of the four times extracted residue, R3, to sensitize mice to show an accelerated rejection indicated that most of the active material could be floated out of the R1 fraction. In order to determine the relative potency of the antigenic extracts, the Pi fraction was washed to remove the sucrose, and the washed preparation, P2, injected in varying amounts (Table 2) . A significant decrease in the MST was observed following the injection of 50 micrograms of the antigenic fraction and an apparent, though not statistically significant, effect was observed with 5 micrograms. Tumor graft rejection-The activity of the various fractions in eliciting an immunity to a subsequent graft of tumor cells is shown in Table 1 . In addition to the fractions that showed activity in the skin homograft test, R1 and P1, protection was also apparent following injections of fractions S1 and R3. The relative effect of varying amounts of antigen upon subsequent tumor challenge is indicated in Table   2 .
It may be noted that, both quantitatively and qualitatively, the data indicate that accelerated tumor graft rejection was a more sensitive indicator of the antigenic activity of the various fractions than was the rejection of skin homografts. Whether this was a reflection of a real differential sensitivity of the two grafts to the same antigen, the presence of more than one antigen in the fraction, or the variable response of the two strains of mice used in the respective assays is not yet known.
Serological tests: In Tables 3 and 4 are presented data showing that the P2 fraction has the ability to combine specifically with anti-DBA/2 hemagglutinins and cytotoxins produced in C3H and C57B1/6 mice. The specificity of the hemagglutinin inhibition described in Table 3 is indicated by the differential inhibition of antibodies against DBA/2 and C3H cells in a C57B1 anti-C3H serum of comparable strength. Similarly, the failure of the antigen extracts to affect the cytotoxic antibodies in a DBA/2 anti-C3H serum (Table 4) , while reducing the effectiveness of a C57B1 anti-L-5178Y serum to destroy lymph cells of DBA/2 mice, would suggest that the absorptions of the sera are specific.
In Table 5 are presented the titers of sera obtained following the hyper-immunization of mice of two strains, C3H and C57B1/6, with the P2 fraction. Both strains responded with antibodies that agglutinated DBA/2 erythrocytes, although the titer of serum obtained from the C57B1/6 mice was somewhat higher than that obtained from C3H mice. The sera were tested also for the presence of cytotoxic antibodies but without success. This is perhaps not surprising since the development of cyto- Saline  DBA/2  1  3  4  3  2  0  C3H anti-L-5178Y  C3H  0 toxins to a detectable titer frequently occurs less readily in mice than does the production of hemagglutinins. A variation of dose and injection schedules as well as use of one of the more sensitive cytotoxic tests should permit the detection of cytotoxins if such are formed in response to the extracted antigens. Chemical characteristics: The antigenic fraction P2 is homogeneous with respect to density. After prolonged centrifugation at 100,000 X g, only one visible band was obtained in either a sucrose gradient or a cesium chloride gradient. While the density of the fraction in sucrose was approximately 1.13-1.14, in cesium chloride it was 1.16-1.18, suggesting that the material had dissociable groups able to bind cesium. Dried preparations of P2 were 60% protein, while the rest was largely lipid. On extraction of the dried material with lipid solvents, 70% of the dry weight dissolved. It appeared that the antigen was a complex lipoprotein with a significant phospholipid content. It had properties which strongly resembled those associated with high density lipoprotein fractions found in many animal sera.: A detailed account of the chemical properties of the antigenic fraction will be published separately.
From 20 gm, wet weight, of L-5178Y cells, approximately 60 mg of antigen measured as protein may be obtained. The fraction was approximately 60% protein; therefore, the total content of 20 gm of cells must be at least 100 mg of antigen. Since the dry weight of 20 gm of cells is about 3.3 gm, it would appear that at least 3% of the cell's contents is antigenically active.
Discussion.-In the earlier attempts9-12 to extract transplantation antigens from mouse tissues, aqueous solutions of low specific gravity, in which the antigens were insoluble, were used, and it was found that the antigenically active material was sedimented as part of the microsome fraction. The lipoprotein nature of some cell antigens from liver tissue was demonstrated by Herzenberg and Herzenberg,13 who obtained a fraction of density less than 1.22 which combined specifically in vitro with H-2 agglutinins and which contained about 30% lipid. The antigenic activity of the material in vivo was not reported. It is not known how many antigens or antigenic determinants may be present in the lipoprotein fraction (P2) isolated from L-5178Y cells. For several reasons it would seem reasonable to conclude that at least some of the H-2 antigenic moiety is certainly present. The rapidity with which the P2 fraction induced an immunity which caused an accelerated rejection of skin homografts would suggest an antigenic potency comparable to that associated with the H-2 locus in mice, and unlike the weaker histocompatibility antigens of this species. Also, the absorption of agglutinating and cytotoxic antibodies from mouse isoimmune sera is indirect evidence that H-2 haptens are present in the preparation, since the detectable humoral antibodies elicited by isoimmunization in mice almost invariably include those directed against the H-2 antigens. Finally the most direct evidence that the P2 fraction contained H-2 antigens was the production of agglutinins in mice following hyperimmunization with relatively small amounts of antigen. Non-H-2 antigens do elicit humoral antibodies after extensive hyperimmunization, but do so less frequently in the absence of an H-2 difference.'6 The use of co-isogenic lines of mice should provide direct evidence of the completeness of the H-2 antigenic determinants present in the P2 fraction.
Summary.-A murine lymphoblast, L-5178Y, grown in tissue culture, has been used as a source of histocompatibility antigens. A lipoprotein fraction has been isolated which will sensitize mice to show an accelerated rejection of skin homografts and tumor grafts, will elicit and combine with specific hemagglutinins, and will combine with specific cytotoxins. The fraction is homogeneous with respect to density. Most of the detectable antigenic activity extractable from the cells is in this fraction.
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